Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2008-08-11 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction (Sale) by a person in a managerial role ("Roland Berger" as "Member of an administrative or supervisory body") involving the company's ordinary shares. This directly corresponds to the definition of Director's Dealing, which is classified as code DIRS.
2008-08-11 English
Q2 Report 2008
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for the Fresenius Group covering the 1st Half and 2nd Quarter of 2008. It contains detailed financial statements (income statement, balance sheet, cash flow), management discussion and analysis (MDA), and segment reporting. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2008
2008-08-06 English
6-Monatsbericht 2008
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quartalsfinanzbericht' (Quarterly Financial Report) for Fresenius for the first half and second quarter of 2008. It contains comprehensive financial statements, including the consolidated income statement, balance sheet, cash flow statement, and segment reporting, as well as a detailed management analysis of the financial situation. It is not an announcement or a summary, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2008
2008-08-06 German
Analyst Meeting - H1/2008 Results
Investor Presentation Classification · 95% confidence The document is titled 'Analyst Meeting – H1/08 Results' and contains detailed financial tables, segment performance updates, and management commentary regarding the H1 2008 period. It is clearly a presentation deck used for an investor or analyst meeting to discuss financial results. According to the filing definitions, this fits the 'Investor Presentation' (IP) category, as it provides detailed financial data, strategy, and market position updates for investors. H1 2008
2008-07-30 English
Fresenius SE: Mandatory exchangeable bonds offering successfully executed
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc' announcement dated July 17, 2008, detailing the successful execution and pricing of a €554 million offering of mandatory exchangeable bonds by Fresenius SE. This announcement concerns fundraising, debt issuance, and capital structure activities involving the exchange for shares of a subsidiary (Fresenius Medical Care). This clearly falls under the definition of 'Capital/Financing Update'. The document is a direct announcement of a financing event, not a general regulatory filing (RNS) or a report itself.
2008-07-17 English
Fresenius SE: Issuance of mandatory exchangeable bonds
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc' announcement dated July 17, 2008, detailing the 'Issuance of mandatory exchangeable bonds' by Fresenius SE, involving a nominal amount of up to €600 million. This clearly describes a corporate action related to fundraising, debt issuance, and capital structure modification. This aligns directly with the definition of 'Capital/Financing Update' (Code: CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV).
2008-07-17 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.